Renovaro Inc.'s leadership foresees AI and biotech fusion revolutionizing healthcare, enhancing precision, effectiveness, and accessibility. They also predict faster detection and treatment of cancer and other diseases due to their combined capabilities.
$Renovaro(RENB.US)$Renovaro Biosciences' (RENB) said its shareholders approved at a special meeting on Thursday the issuance of common shares under a stock purchase agreement with GEDi Cube. The two companies have agreed to merge, with artificial intelligence medical technology firm GEDi becoming a wholly-owned subsidiary of Renovaro in a stock-for-stock acquisition.
Renovaro股票討論
新聞
RenovaRoCube 將收購 Cyclomics 的 100% 所有權,加強尖端癌症診斷合作夥伴關係
RenovaRoCube 收購 Cyclomics 的 100% 所有權,加強他們在癌症診斷方面的合作。
與牛津納波雷和英維亞的合作關係增強了 RenovaRoCube 在早期癌症檢測和治療監測方面的能力。
RenovaRoCube 的開放架構 AI 平台結合 Cyclomics 的第四代分子技術可實現準確的...
The two companies have agreed to merge, with artificial intelligence medical technology firm GEDi becoming a wholly-owned subsidiary of Renovaro in a stock-for-stock acquisition.
暫無評論